Article
Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine
2022-05-31
Abstract excerpt
<h4>ABSTRACT</h4> Transcriptome profiling is a mainstay of translational cancer research and is increasingly finding its way into precision oncology. While bulk RNA sequencing (RNA-seq) is widely available, high costs and long data return time are limiting factors for clinical applications. We investigated a portable nanopore long-read sequencing device (MinION, Oxford Nanopore Technologies) for transcriptome pro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c6617344-0852-5eb7-aed2-bfdb47b66268
- DOI
- 10.1101/2022.05.31.494109
